ArticleJCO precision oncology2021

Excellent Response With Alpelisib and Bicalutamide for Advanced Salivary Duct Carcinoma With PIK3CA Mutation and High Androgen Receptor Expression-A Case Report.

Hardik Sheth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.